Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7126364 | 0.79 | KDM4E (0.32) | IDO1TDO2KDM4EALDH1A1TDP1 | |
| SCHEMBL7119984 | 0.76 | KDM4E (0.32) | KDM4E | |
| SCHEMBL9908399 | 0.72 | MEN1 (0.32) | ALDH1A1MEN1KMT2A | |
| SCHEMBL10976261 | 0.70 | KDM4E (0.38) | IDO1TDO2KDM4EALDH1A1TDP1 | |
| SCHEMBL14330304 | 0.69 | — | — | |
| SCHEMBL6276072 | 0.69 | LMNA (0.39) | — | |
| SCHEMBL4833162 | 0.69 | LMNA (0.39) | — | |
| SCHEMBL13986503 | 0.69 | LMNA (0.39) | — | |
| SCHEMBL14117842 | 0.69 | KDM4E (0.43) | IDO1TDO2KDM4EALDH1A1TDP1 | |
| SCHEMBL10946796 | 0.69 | KDM4E (0.42) | IDO1TDO2KDM4EALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6660448-B2 | Lactone ring-substituted norbornene based polymers; photoresists; resolution, etching resistance, use in micropatterning with electron beams or deep-ultraviolet radation | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-12-09 | — | — | US | disclosed |
| US-6500961-B2 | MICROSTRUCTURE PATTERNS FOR PHOTORESISTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-20020091215-A1 | Polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-07-11 | — | — | US | disclosed |
| US-20020019545-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019545-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | RACK1, MRPS22, ECH1 | IDO1 4161/4885TDO2 4708/4885KDM4E 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.